Ensign Peak Advisors, Inc Shattuck Labs, Inc. Transaction History

Ensign Peak Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.22 - $8.89 $332,628 - $700,727	-78,822 Reduced 93.63%	5,360 $23,000
Q4 2021 Feb 11, 2022	BUY	$8.36 - $21.08 $212,009 - $534,588	25,360 Added 43.11%	84,182 $717,000
Q3 2021 Nov 12, 2021	BUY	$17.57 - $28.95 $506,402 - $834,396	28,822 Added 96.07%	58,822 $1.2 Million
Q4 2020 Feb 12, 2021	BUY	$19.0 - $57.61 $570,000 - $1.73 Million	30,000 New	30,000 $1.57 Million

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.